Product innovation and growth

The R&D is the main axis of development of EVOLUTIS.

Besides the permanent improvement of the already launched on the market implantable devices, EVOLUTIS commits every year a significant part of the annual turnover in the development of new implants, every new generation of which brings a considerable improvement for the patient and for his(her) surgeon in term of long-term security, improvement of the functional outcomes, the reduction of the complications and the ease of use.

4 new projects each year

While limiting itself voluntarily to its fields of expertise (hip, knee, and upper limb), EVOLUTIS maintains a permanent and international technology watch. This drives EVOLUTIS to develop permanently its product portfolio in order to adapt to the evolution of the existing markets, and to comply with the new developping markets.

The  R&D department is busy developping 4 new complete projects on average each year, and up to 10 projects of evolution of implants or existing instruments.

A continuous growth since the company was created

EVOLUTIS shares its activity between direct, or through business partners, marketing in France and at the international of EVOLUTIS brand prostheses, and the design and manufacture in subcontracting of OEM prostheses marketed by other orthopaedic companies.

This dual positioning allowed EVOLUTIS to grow every year since its creation in 1999, in spite of a national market close to the stagnation, and an increasing pressure of healthcare governmental systems of most countries on the prices.

Today EVOLUTIS realizes 1/3 of its business on export markets and wishes to pursue international development as a priority.

Turnover evolution chart since EVOLUTIS was created in 1999